Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed 12/20/13 Boston
Hologic Names New CEO, Cuts Deal With Icahn to Avoid Proxy Fight 12/09/13 Boston
5AM Ventures, an Early Stage Biotech VC Still Standing, Raises $250M 12/04/13 San Francisco
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Hologic, Fending off Icahn, Adopts Poison Pill to Deflect Takeover 11/21/13 Boston
Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs 11/20/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs 10/02/13 Boston
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
X-Chem, Aiming For Tough-to-Drug Targets, Cuts Deal With AstraZeneca 09/25/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Broad Institute Joins up with Bayer to Find Targeted Cancer Drugs 09/10/13 Boston
Disappointments, New Prospects for Rigel Pharmaceuticals 09/10/13 San Francisco
Sage Taps Former Shire Exec to Lead CNS Drugs Into Clinical Trials 08/14/13 Boston
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Array Starts First Phase 3 Trial, Shifts to Late-Stage Development 07/03/13 Boulder/Denver
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
Constructing Innovation Supply Chains for the Pharmaceutical Industry 06/26/13 Boston
NGM, Partners Seek Next Diabetes Drug Targets Among GI Tract Hormones 06/25/13 San Francisco
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Page 2 of 6 « previous page · next page »